Similarly, for colorectal cancer patients, higher expression of Ephexin1 and EphA2 correlated to worse survival rates, and lower expression of EphA3 correlated to worse survival rates (Supplementary Fig. S1b, c). The gene discussed is EPHA2; the disease is colorectal cancer.